fashion -WSS

fashion

author：comprehensive 2025-09-14 11:49:08 - browse：1

The Food and Drug Administration’s advisory panel of pediatric experts met on Tuesday to discuss advances in artificial womb technology, which aim to save the lives of premature babies.

The goal of the meeting was to discuss measures for evaluating the safety and efficacy of an artificial womb. The group grappled with the limits of current animal data, as well as the ethical difficulties in running human trials. On Wednesday, the committee’s meeting will be closed to the public in order to protect trade secrets.

Extremely premature babies, defined as infants born at less than 28 weeks, rarely survive. About half of infants born at 23 weeks survive, according to a 2022 study in the Journal of the American Medical Association, and at 22 weeks just 10% survive. This population represents less than 2% of all premature babies, but the problem is growing; the Centers for Disease Control and Prevention reported that the preterm birth rate rose by 4% between 2020 and 2021.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： The stability of $0 premiums in Medicare Advantage

hotspot

WSS

FDA gives detailed accounting of AI

Why health workers in Gaza are injured or die at high rates

Medicare reduced heart disease by changing how it pays doctors

Will an HIV vaccine ever be a reality?

IVG is promising — but it won’t replace IVF quite yet

Researchers explore possible ties between long Covid, menopause

focus

fashion

focus

Hepatitis C has a cure — but many Americans still lack access to it

With Roe v Wade overturned, abortion providers work to adapt

As demand for Covid shots wanes, Moderna seeks its next success

What we owe ALS patients — and why one company fell short

Medical leaders decry Supreme Court decision on affirmative action

What will Novo Nordisk's VC do with its influx of cash?

Activists slam private health insurers over coverage restrictions

The explosion of genetic testing requires a new approach

The cancer drug shortage isn’t new — and neither are the solutions

CEOs share strategies for surviving biotech slump

focus

Hospital price transparency does save money, advocate argues

STAT Readout Newsletter: Today's biggest biotech updates

CRISPR base editing slashes cholesterol levels in monkeys

Impact of Dobbs ruling felt at reproductive medicine meeting

Medicare innovation center doesn’t save money, experts say

Will Ozempic

hotspot

entertainment

hotspot

focus